Mirum Pharmaceuticals (MIRM) Current Leases (2019 - 2024)
Mirum Pharmaceuticals (MIRM) posted quarterly Current Leases of $1.7 million for Q4 2024, up 54.8% year-over-year from $1.1 million in Q1 2024, and up 13.48% quarter-over-quarter from $1.5 million in Q3 2024.
Mirum Pharmaceuticals (MIRM) Current Leases (2019 - 2024) Analysis & Trends
Mirum Pharmaceuticals' Current Leases history runs 6 years deep, the most recent figure standing at $1.7 million for Q4 2024.
- In Q4 2024, Current Leases rose 54.8% year-over-year to $1.7 million; the TTM figure through Dec 2024 stood at $1.7 million (up 54.8% YoY), while the FY2024 annual figure was $1.7 million, up 54.8% from the prior year.
- Current Leases for Q4 2024 stood at $1.7 million, up from $1.5 million in the prior quarter.
- The five-year high for Current Leases was $1.7 million in Q4 2024, with the low at $358000.0 in Q1 2024.
- The 5-year median for Current Leases is $741500.0 (2022), against an average of $850800.0.
- The sharpest annual moves came in 2020 and 2024: Current Leases surged 139.82% in 2020, then slumped 60.83% in 2024.
- Mirum Pharmaceuticals' Current Leases stood at $636000.0 in 2020, then grew by 11.79% to $711000.0 in 2021, then jumped by 30.94% to $931000.0 in 2022, then increased by 18.58% to $1.1 million in 2023, then surged by 54.8% to $1.7 million in 2024.
- Business Quant data shows MIRM's Current Leases at $1.7 million in Q4 2024, $1.5 million in Q3 2024, and $1.1 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.71 Mn |
| Sep 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 358,000.00 |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 1.06 Mn |
| Mar 31, 2023 | 914,000.00 |
| Dec 31, 2022 | 931,000.00 |
| Sep 30, 2022 | 775,000.00 |
| Jun 30, 2022 | 752,000.00 |
| Mar 31, 2022 | 731,000.00 |
| Dec 31, 2021 | 711,000.00 |
| Sep 30, 2021 | 690,000.00 |
| Jun 30, 2021 | 671,000.00 |
| Mar 31, 2021 | 653,000.00 |
| Dec 31, 2020 | 636,000.00 |
| Sep 30, 2020 | 616,000.00 |
| Jun 30, 2020 | 530,000.00 |
| Mar 31, 2020 | 511,000.00 |